Effect of zeta potential on the properties of nano-drug delivery systems - A review (Part 2)

Tropical Journal of Pharmaceutical Research

Volumn 12, Issue 2, 2013, Pages 265-273

  Honary, Soheyla ^a   Zahir, Foruhe ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dosage form stability; Drug targeting; Nano medicines; Site specific release; Zeta potential

Indexed keywords

ALPRENOLOL; CALCITONIN; CHITOSAN; DNA; DOUBLE STRANDED RNA; DOXORUBICIN; FLURBIPROFEN; HYALURONIC ACID; LABETALOL; LIPOSOME; MACROGOL; NANOPARTICLE; OCTADECYLAMINE; POLYETHYLENEIMINE; POLYGLACTIN; POLYLACTIDE; POLYMER; PROPRANOLOL; SMALL INTERFERING RNA; TETANUS TOXOID; TETRACAINE;

ARTICLE; CONTROLLED DRUG RELEASE; CYTOTOXICITY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; GENE DELIVERY SYSTEM; HUMAN; IMMUNOGENICITY; INTESTINE; INTRAOCULAR DRUG ADMINISTRATION; MACROPHAGE; MUCOADHESION; NANOMEDICINE; NANOTOXICOLOGY; NONHUMAN; RESPIRATORY SYSTEM; ZETA POTENTIAL;

EID: 84876906085     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v12i2.20     Document Type: Article

References (60)

1. Pan J, Shen Feng S. Targeting and imaging cancer cells by Folate-decorated, quantum dots (QDs)- loaded nanoparticles of biodegradable polymers. Biomaterials 2009; 30: 1176-1183.
2. Makhlof A, Werle M, Tozuka Y, Takeuchi H. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. J. Control. Release 2011; 149: 81-88.
3. Quaglia F, Ostacolo L, Mazzaglia A, Villari V, Zaccaria D, Sciortino MT. The intracellular effects of nonionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs. Biomaterials 2009; 30: 374-382.
4. Feng S, Ruanb G, Lic Q. Fabrication and characterizations of a novel drug deliverydevice liposomes-in microsphere (LIM). Biomaterials 2004; 25: 5181-5189.
5. Zaru M, Manca M, Fadda AM, Antimisiaris SG. Chitosan-coated liposomes for delivery to lungs by nebulisation. Colloid Surfaces B 2009; 71: 88-95.
6. Qi L, Xu Z, Jiang X, Li Y, Wang M. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles Bioorgan. M.d. Chem. Lett. 2005; 15:1397-1399.
7. Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. Emerging nanopharmaceuticals. Nanomed-Nanotechnol 2008; 4: 273-282.
8. Unger F, WIittmar M, Kissel T. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graftpoly(d,l-lactide-co-glycolide): Effects of polymer structure on cytotoxicity. Biomaterials 2007; 28: 1610-1619.
9. Barratt GM. Therapeutic applications of colloidal drug carriers. Pharm. Sci. Technol. Today 2000; 3: 163-171.
10. Wang J, Feng S, Wang S, Chen Z. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment', Int. J. Pharmaceut. 2010; 400: 194-200.
11. Lee SY, Huh MS, Lee S, Lee SJ, Chung H, Park JH, Oh YK, Choi K, Kim K, Kwon IC. Stability and cellular uptake of polymerized siRNA (polysiRNA)/polyethylenimine (PEI) complexes for efficient gene silencing. J. Control. Release 2010; 141: 339-346.
12. Raemdonck K, Naeye B, Høgset A, Demeester J, De Smedt SC. Prolonged gene silencing by combining siRNA nanogels and photochemical internalization. J. Control. Release 2010; 145: 281-288.
13. Lee AL, Wang Y, Cheng HY, Pervaiz S, Yang YY. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials 2009; 30: 919-927.
14. Sarmento B, Mazzaglia D, Bonferroni MC, Neto AP, Monteiro MC, Seabra V. Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system', Carbohyd. Polym 2011; 84: 919-928.
15. David Needham, Ana Ponce. Nanoscale drug delivery vehicles for Solid tumors, Nanotechnology for cancer therapy, CRC Press, Taylor & Francis; 2002; p 677.
16. He M, Zhao Z, Yin L, Tang C, Yin C. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. Int. J. Pharm., 2009; 373: 165-173
17. He M, Hua Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010; 31: 3657-3666.
18. Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 1995; 270: 16221-16224.
19. Arnida M, Janát-Amsbury MM, Ray A, Peterson CM, Ghandehari H. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur. J. Pharm. Biopharm. 2011; 77: 417-423.
20. Obata Y, Tajima S, Takeoka S. Evaluation of pHresponsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. J. Control. Release 2010; 142: 267-276. 28 L1
21. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliver. Rev. 2008; 60: 1615-1626.
22. Csaba N, Garcia-Fuentes M, Alonso MJ. Nanoparticles for nasal vaccination. Adv. Drug Deliver. Rev. 2009; 61: 140-157.
23. Hagigit T, Abdulrazik M, Orucov F, Valamanesh F, Lambert M, Lambert G, Behar-Cohen F, Benita S. Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye. J. Control. Release 2010; 145: 297-305.
24. Luoa Q, Zhao J, Zhanga X, Pan W. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int. J. Pharmaceut. 2011; 403: 185-191.
25. Das S, Suresh PK. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B. Nanomed-Nanotechnol2011; 7: 242
26. Jain JK, Pathana SA, Akhtera S, Jayabalanb N, Talegaonkara S, Khara RK, Ahmada FJ. Microscopic and spectroscopic evaluation of novel PLGA-chitosan Nanoplexes as an ocular delivery system. Colloid. Surface. B. 2011; 82: 397-403.
27. Khdair A, Chen D, Patil Y, Ma L, Dou P, Shekhar M, Panyam J. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. J. Control. Release 2010; 141: 137.
28. Prokop A, Kozlov E, Carlesso J, Davidson M. Hydrogelbased colloidal polymeric system for protein and drug delivery: physical and chemical characterization permeability control and applications. Adv. Polymer res. 2002; 160: 119-173.
29. Prokop A, Kozlov E, Carlesso J, Davidson M. Hydrogelbased colloidal polymeric system for protein and drug delivery: physical and chemical characterization permeability control and applications. Adv. Polymer res. 2002; 160: 119-173.
30. Beck-Broichsitter M, Ruppert, C, Schmehl T, Guenther A, Betz T, Bakowsky U, Seeger W, Kissel T,Gessler T. Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro. Nanomed-Nanotechnol 2011; 7: 341-350.
31. Harush-Frenkel O, Bivas-Benita M, Nassar T, Springer C, Sherman Y, Avital A, Altschuler Y, Borlak J, Benita S. A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery. Toxicol. Appl. Pharm. (2010) 246; 83-90.
32. Khan MK. Nigavekar SS, Minc LD, Kariapper MS, Nair BM, Leniak WG, Balogh LP. In vivo biodistribution of dendrimers and dendrimer nanocomposites --implications for cancer imaging and therapy. Technol. Cancer Res. Treat. 2005; 4: 603-613.
33. Cal C, Bakowsky U, Rytting E, Scharper AK, Kissel T. Charged nanoparticles as protein delivery systems: A feasibility study using lysozyme as model protein. Eur. J. Pharm. Biopharm. 2008; 69: 31-42.
34. Patila S, Sandberg A, Heckert E, Self W, Sea S. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 2007; 28: 4600-4607.
35. Puttipipatkhachorn S, Nunthanid J, Yamamotoc K, Peck GE. Drug physical state and drug-polymer interaction on drug release from chitosan matrix films. J. Control. Release 2001; 75: 143-153.
36. Kim JO, Kabanov AV, Bronich TK. Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. J. Control. Release 2009; 138: 197-204.
37. Hirsjärvi S, Peltonen L, Hirvonen J. Layer-by-layer polyelectrolyte coating of low molecular weight poly (lactic acid) nanoparticles. Colloid. Surface. B, 2006; 49: 93-99.
38. Honary S, Jahanshahi M, Golbayani P, Ebrahimi P, Ghajar K. Doxorubicin-loaded albumin nanoparticles: formulation and Characterization. J. Nanosci. Nanotechno. 2010; 10: 7752-7757.
39. Honary S, Ebrahimi P, Tabbakhian M, Zahir F. Formulation and characterization of Doxorubicin nanovesicles. J. Vac. Sci. Technol. B, 2009; 27: 1573-1577.
40. Nishiyama N, Kataok K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Therapeut. 2006; 112: 630-648.
41. Kawano K, Takayama K, Nagai T, Maitani Y. Preparation and pharmacokinetics of pirarubicin loaded dehydration-rehydration vesicles. Int. J. Pharm. 2003; 7379.
42. Lee ES, Gao Z, Bae Y. Recent progress in tumor pH targeting nanotechnology. J. Control. Release 2008; 132: 164-170.
43. Csaba N, Garcia-Fuentes M, José Alonso M. The performance of nanocarriers for transmucosal drug delivery. Expert Opin. Drug Del. 2006; 3: 463-478.
44. Jung T, Kamm W, Breitenbach A, Hungerer K, Hundt E, Kissel T. Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice. Pharm. Res. 2001; 3: 352-360.
45. J Harting SM, Greene RR, Dikov MM, Prokop A, Davidson JM. Multifunctional nanoparticulate polyelectrolyte complexes. Pharm. Res. 2007; 24: 2353-2369.
46. Sawant K, Dodiya S. Recent Advances and Patents on Solid Lipid Nanoparticles. Recent Pat. Drug Deliv. Formul. 2008; 2: 120-135.
47. Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting' Nanomed-Nanotechnol. 2010; 6: 714-729.
48. Lambert O, Benoit JP, Pitard B. Encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials 2009; 30: 3197-3204.
49. Hoeller S, Sperge, A, Valenta C. Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. Int. J. Pharm. 2009; 370: 181-186.
50. Wissinga SA, Kayserb O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliver. Rev. 2004; 56: 1257-1272.
51. Jacobs C, Kayser O, Müller R.H. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int. J. Pharm.2000; 196: 161-164.
52. Quaglia F, Ostacolo L, Mazzaglia A, Villari V, Zaccaria D, Sciortino MT. The intracellular effects of nonionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs. Biomaterials 2009; 30: 374-382.
53. Makhlof A, Werle M, Tozuka Y, Takeuchi H. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. J. Control. Release 2011; 149: 81-88.
54. Liu J, Hu W, Chena H, Nib Q, Xua H, Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin mtargeting for topical delivery. Int. J. Pharm. 2007; 328: 191-195.
55. Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future. Adv. Drug Deliver. Rev. 2001; 47: 3-19.
56. Feng S, Ruanb G, Lic Q. Fabrication and characterizations of a novel drug deliverydevice liposomes-in microsphere (LIM). Biomaterials 2004; 25: 5181-5189.
57. Qi L, Xu Z, Jiang X, Li Y, Wang M. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles Bioorgan. M.d. Chem. Lett. 2005; 15:1397-1399.
58. Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. Emerging nanopharmaceuticals. Nanomed-Nanotechnol 2008; 4: 273-282.
59. Unger F, WIittmar M, Kissel T. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-covinyl alcohol]-graft-poly(d,l-lactide-co-glycolide) : Effects of polymer structure on cytotoxicity. Biomaterials 2007; 28: 1610-1619.
60. Barratt GM. Therapeutic applications of colloidal drug carriers. Pharm. Sci. Technol. Today 2000; 3: 163-171.